|1.||Ohtsuka, Takao: 2 articles (07/2004 - 03/2003)|
|2.||Lee, Sam W: 2 articles (07/2004 - 03/2003)|
|3.||Xu, Jian: 1 article (07/2015)|
|4.||Ma, Ze-Gang: 1 article (07/2015)|
|5.||He, Feng: 1 article (07/2015)|
|6.||Barouch-Bentov, Rina: 1 article (04/2015)|
|7.||Kovackova, Sona: 1 article (04/2015)|
|8.||Einav, Shirit: 1 article (04/2015)|
|9.||Heroven, Christina: 1 article (04/2015)|
|10.||Šála, Michal: 1 article (04/2015)|
|1.||Parkinson Disease (Parkinson's Disease)
07/01/2015 - "The aim of this meta-analysis was to evaluate the association between cyclin G-associated kinase (GAK) rs1564282 C/T polymorphism and Parkinson's disease (PD) susceptibility. "
04/15/2011 - "Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study."
01/01/2013 - "Cyclin G-associated kinase (GAK) modifies α-synuclein expression levels and affects the susceptibility of Parkinson's disease (PD). "
01/01/2012 - "Numerous GWAS linked loci including BST1 (bone marrow stromal cell antigen 1), PARK16 (parkinson disease 16 susceptibility), GAK (cyclin G associated kinase), and HLA (human leukocyte antigen) have also been identified. "
08/01/2009 - "This study was purposed to explore the expression of P27(kip1)and cyclin G in patients with acute leukemia (AL) and its correlation. "
08/01/2009 - "[Expression of P27(kip1) and cyclin G in patients with acute leukemia and its correlation]."
11/15/1996 - "It is therefore important to examine whether chromosomal translocations around this region cause aberrant cyclin G expression in a manner that is causally related to leukemia."
|3.||Colorectal Neoplasms (Colorectal Cancer)
11/01/2003 - "The present study demonstrates that cyclin G overexpression is a frequent event in colorectal cancer. "
11/01/2003 - "This frequent event in colorectal carcinogenesis may facilitate new therapeutic approaches acting as a target for gene therapy, possibly directed at downregulating cyclin G in colorectal cancer."
11/01/2003 - "Ninety-one percent of colorectal tumors had cyclin G overexpression. "
11/01/2003 - "A better cell cycle target for gene therapy of colorectal cancer: cyclin G."
11/01/2003 - "The purpose of this study was to evaluate the overexpression of cyclin G in colorectal neoplasia, which may be a more frequent event than cyclin D1 during the cell cycle and thus may have a more enhanced therapeutic potential in treating colorectal cancer. "
03/01/2012 - "Abnormal expression of cyclin G was closely related to tumor differentiation, the origin, and progression of NPC."
03/20/2003 - "Cyclin G is a transcriptional target gene of tumor suppressor p53. "
08/12/1999 - "Cyclin G was previously identified as a target gene of the p53 tumor suppresser protein, and levels of cyclin G are increased after induction of p53 by DNA damage. "
12/01/1998 - "Amplification of cyclin G was not observed in any of the tumors by Southern blot hybridization with a cyclin G probe. "
12/01/2001 - "In a larger panel of 75 pancreatic adenocarcinomas, these 7 MICPs (ppENK, Cyclin G, ZBP, MICP25, 27, 36, and 38) were methylated in 93, 3, 9, 15, 48, 19, and 41% of cancers, respectively, by methylation-specific PCR but not in any of 15 normal pancreata. "
|5.||Prostatic Neoplasms (Prostate Cancer)
04/16/1999 - "We have identified cyclin G as being overexpressed in breast and prostate cancer cells using differential display polymerase chain reaction screening. "
04/16/1999 - "We demonstrate here that cyclin G is overexpressed in human breast and prostate cancer cells and in cancer cells in situ from tumor specimens. "
01/01/2014 - "Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630."
03/01/2006 - "Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer."
|5.||Qa-SNARE Proteins (Syntaxin)
|9.||Protein-Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)